Results 91 to 100 of about 1,885 (156)

Case Report: BKV-specific T cells: a fast, safe and potentially effective treatment option for refractory BKV infections in pediatric patients after allogeneic stem cell transplantation. [PDF]

Front Pediatr
Oberwegner S, Hettler SA, Hensen L, Heinz AT, Braun C, Döring M, Lang P.   +6 more
europepmc   +1 more source

Rethinking mpox: epidemiology, clinical variants, diagnosis, and response. [PDF]

Osong Public Health Res Perspect
Thakur R, Rajput DPS, Agrawal NR, Agrawal A.   +3 more
europepmc   +1 more source

Correction: Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir

Signal Transduction and Targeted Therapy
Yifan Zhang, Yanmin Wan, Cuiyuan Guo, Zhaoqin Zhu, Chao Qiu, Jiasheng Lu, Yanan Zhou, Jiaojiao Zheng, Fahui Dai, Xiaoyang Cheng, Kunlu Deng, Wanhai Wang, Youchun Wang, Wenhong Zhang   +13 more
doaj   +1 more source

Mpox: disease manifestations and therapeutic development. [PDF]

J Virol
Wang Y, Wang X, Doğan T, Sam-Agudu NA, Al-Tawfiq JA, Pan Q.   +5 more
europepmc   +1 more source

From outbreak to opportunity: Sierra Leone's mpox crisis as a wakeup call for pandemic equity. [PDF]

Int J Equity Health
Bai-Sesay AU, Jones RD, Sesay DKD.
europepmc   +1 more source

Tecovirimat is active against various MPXV strains, while cidofovir, brincidofovir, trifluridine, and gemcitabine have no detectable MPXV-specific antiviral activity. [PDF]

Virus Res
Higashi-Kuwata N, Kato M, Hattori SI, Takamatsu Y, Mitsuya H.   +4 more
europepmc   +1 more source

Boosting the Predictive Power of Virus-Specific T-Cell Clinical Trials via Generative Models. [PDF]

Comput Struct Biotechnol J
Chansky P, Rubinstein J, Grimley M, Davies SM, Blyth E, Gottlieb D, Pulsipher MA, Bollard C, Keller MD, Li W.   +9 more
europepmc   +1 more source

Monkeypox (Mpox): a comprehensive review of epidemiology, therapeutic advances, and public health implications. [PDF]

J Health Popul Nutr
Verma A, Sharma S, Khatik GL, Suttee A, Kumar D, Choudhary N, Kondaveeti SB.   +6 more
europepmc   +1 more source

Therapeutic Innovations for Monkeypox Inhibition. [PDF]

Int J Mol Sci
De N, Bhadra J, Momin MSA, Mitra K, Bhunia D, Sannigrahi A.   +5 more
europepmc   +1 more source

In-silico discovery of type-2 diabetes-causing host key genes that are associated with the complexity of monkeypox and repurposing common drugs. [PDF]

Brief Bioinform
Ajadee A, Mahmud S, Ali MA, Mollah MMH, Ahmmed R, Mollah MNH.   +5 more
europepmc   +1 more source